| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Syngene International Limited (NSE: SYNGENE)
SYNGENE Technical Analysis
4
| As on 29th Apr 2024 SYNGENE SHARE Price closed @ 697.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 740.49 & Sell for SHORT-TERM with Stoploss of 715.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SYNGENESHARE Price
| Open | 691.20 | Change | Price | % |
| High | 701.30 | 1 Day | -1.40 | -0.20 |
| Low | 689.15 | 1 Week | -8.05 | -1.14 |
| Close | 697.20 | 1 Month | -5.35 | -0.76 |
| Volume | 957669 | 1 Year | 20.20 | 2.98 |
| 52 Week High 843.55 | 52 Week Low 526.65 | ||||
| SYNGENE CURRENT MONTH FUTURE | |||
| Close | 704.75 | ||
| Contracts Traded | 3144000 | ||
| Open Intrest | 6808000 | ||
| Change In O.I | 0.03 % | ||
| Lot Size | 1000 | ||
| SYNGENE CURRENT MONTH OPTION | |
| Most Active Call | 700.00 |
| Most Active put | 650.00 |
| Highest O.I Buildup Call | 800.00 |
| Highest O.I Buildup Put | 650.00 |
| Expiry Date | 2024-05-30 |
| SYNGENE ALL MONTHS OPTIONS | |||
| For All SYNGENE Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 13.45 | -3.93% |
| YESBANK | 27.10 | 3.63% |
| IDFCFIRSTB | 81.65 | -3.71% |
| MAHABANK | 71.05 | 5.03% |
| GMRINFRA | 87.40 | -3.69% |
| IRFC | 160.90 | 1.80% |
| VAKRANGEE | 27.45 | 7.44% |
| SOUTHBANK | 31.05 | 1.97% |
| NHPC | 93.40 | 0.92% |
| PNB | 137.25 | 0.59% |
NSE INDIA Top Gainers Stocks
| SHIVAMILLS | 110.75 | 19.99% |
| ARCHIDPLY | 141.00 | 19.09% |
| SUPREMEIND | 4955.15 | 14.21% |
| SARLAPOLY | 65.30 | 12.20% |
| AARTISURF | 729.70 | 11.75% |
| MAGADSUGAR | 655.45 | 10.55% |
| JCHAC | 1260.85 | 10.48% |
| HARRMALAYA | 188.65 | 10.00% |
| HINDMOTORS | 31.50 | 9.95% |
| DBSTOCKBRO | 55.95 | 9.92% |
NSE INDIA Top Losers Stocks
| SYNGENE Daily Charts |
SYNGENE Intraday Charts |
Whats New @ Bazaartrend |
SYNGENE Free Analysis |
|
|
SYNGENE Important Levels Intraday
| RESISTANCE | 720.61 |
| RESISTANCE | 713.10 |
| RESISTANCE | 708.46 |
| RESISTANCE | 703.82 |
| SUPPORT | 690.58 |
| SUPPORT | 685.94 |
| SUPPORT | 681.30 |
| SUPPORT | 673.79 |
SYNGENE Target April 2024
| 4th UP Target | 920.41 |
| 3rd UP Target | 851.5 |
| 2nd UP Target | 808.91 |
| 1st UP Target | 766.32 |
| 1st DOWN Target | 644.78 |
| 2nd DOWN Target | 602.19 |
| 3rd DOWN Target | 559.6 |
| 4th DOWN Target | 490.69 |
SYNGENE Weekly Target
| 4th UP Target | 800.35 |
| 3rd UP Target | 767.72 |
| 2nd UP Target | 747.55 |
| 1st UP Target | 727.38 |
| 1st DOWN Target | 669.82 |
| 2nd DOWN Target | 649.65 |
| 3rd DOWN Target | 629.48 |
| 4th DOWN Target | 596.85 |
SYNGENE Target2024
| 4th UP Target | 1328.01 |
| 3rd UP Target | 1127.07 |
| 2nd UP Target | 1002.86 |
| 1st UP Target | 878.66 |
| 1st DOWN Target | 524.24 |
| 2nd DOWN Target | 400.04 |
| 3rd DOWN Target | 275.83 |
| 4th DOWN Target | 74.89 |
Syngene International Limited ( NSE INDIA Symbol : SYNGENE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SYNGENE Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 25.53 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -72.01 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 277.43 | |
| 10 Day Avg Volume | Traded 248.97 % More then 10 Day Average Volume | ||
SYNGENE Other Details
| Segment | EQ | |
| Market Capital | 221879664640.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > | |
SYNGENE Address
 |
||
SYNGENE Latest News
SYNGENE Business Profile
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company offers discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also provides exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company offers lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it provides other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter International Inc.; Amgen Inc.; PharmAust Limited; and HiMedia Laboratories. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited. Address: Biocon SEZ, Biocon Park,, Bengaluru, India, 560099
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service